THE ORIGINAL WOUND CARE SOLUTION
|
|
- Myrtle Heath
- 7 years ago
- Views:
Transcription
1 THE ORIGINAL WOUND CARE SOLUTION
2 MEDIHONEY WOUND CARE FIRST CHOICE IN INFECTION CONTROL. Powerful antibacterial barrier effective against more than 200 clinical isolates EXCEPTIONAL ANTIBACTERIAL ACTION AGAINST GRAM -VE AND GRAM +VE BACTERIA Over 200 clinical isolates screened including: Staphylococcus aureus (MRSA & MSSA) Pseudomonas aeruginosa Acinetobacter calcoaceticus Klebsiella pneumoniae The high osmotic potential of Medihoney dressings cleans the wound Waxes in Antibacterial Wound Gel migrate onto wound bed to form a protective layer Antibacterial Wound Gel provides a protective layer which allows for easy dressing removal MIC OF 127 DRUG-RESISTANT CLINICAL ISOLATES ( ) Narelle George, Qld Health Pathology and Scientific Services, Royal Brisbane Hospital Bacteria MRSA / nm* MRSA ESBL VRE Acinetobacter Pseudomonas aeruginosa Minimum Inhibitory Concentration (MIC). * nm: non-multiresistant Concentration of Medihoney (%) Antibacterial Honey 0% 2% 4% 6% 8% 10% 12% 14% 16%
3 MEDIHONEY CASE REPORTS CASE REPORT 1: REDUCING PAIN AND BLEEDING ASSOCIATED WITH DRESSING CHANGES BACKGROUND 78 year old lady with history of lymphoedema, renal failure, epilepsy and peripheral vascular disease. Ulcers had been managed with a number of treatments but ulcer on right leg remained and was very painful. Wound swabs demonstrated the wound infiltrated with Streptococcus pyogenes and Staphylococcus aureus BEFORE TREATMENT AFTER 2 DAYS OUTCOMES Offensive odour removed in hrs. Size of the wound reduced with healing from the edges very noticeable. Pain subsided allowing reduction in analgesia. Dressings proved easier to apply and remove with less distress to the patient. Bleeding was reduced. Patient happier with significantly less pain. Direct material cost savings of over 20%. AFTER 4 WEEKS AFTER 6 MONTHS CASE REPORT 2: POSITIVE EFFECT ON MRSA INFECTIONS IN STERNAL WOUND BACKGROUND 69-year-old gentleman. Underwent Coronary Artery Bypass (4) Grafts. Prophylactic antibiotics were administered as per standard protocol. Stable post-operatively but a sternal wound discharge was noted on day 7. Wound culture confirmed the presence of MRSA. MRSA INFECTION 2 months after sternum opened MRSA infection MRSA CLEARED Day 8: Following application of Medihoney Antibacterial Honey MRSA cleared Day 18: Sternal wound closure Day 8 debridement of the wound, the sternum was left open and a negative pressure vacuum device (VAC) was applied. After 2 months of continuous treatment with IV antibiotics and VAC, sternal wound remained MRSA infected with a heavy exudate. OUTCOMES Within the first week, after application of Medihoney Antibacterial Honey with VAC, wound clear of infection. 18 days after application of Medihoney Antibacterial Honey with VAC, patient returned to the operating theatre for closure of the sternal wound. Medihoney Antibacterial Honey demonstrated a positive effect (-ve wound swabs) when used in a heavily colonised MRSA wound recalcitrant to IV antibiotics and standard wound treatments.
4 CLINICAL RESEARCH OVER THE LAST SIX YEARS, MEDIHONEY PTY LTD HAS LED THE WORLD IN CLINICAL IN VIVO RESEARCH ON MEDICAL HONEYS. MEDIHONEY PTY LTD ACTIVELY SUPPORTS AND SPONSORS IN VIVO AND IN VITRO STUDIES BY LEADING INSTITUTIONS AROUND THE WORLD. PUBLISHED CLINICAL TRIALS 1. A Randomized, Controlled Trial of Topical Exit Site Application of Honey (Medihoney ) Versus Mupirocin for the Prevention of Catheter- Associated Infections in Haemodialysis Patients Prof David Johnson et al, Princess Alexandra Hospital, Brisbane, Australia Journal of the American Society of Nephrology (5): Prospective, open-label, randomised, controlled trial using Medihoney Antibacterial Medical Honey. HYPOTHESIS Medihoney Antibacterial Honey applied topically to the exit sites of haemodialysis catheters will be more effective than topical Mupirocin application in preventing catheter-associated infections. Avoid the problems of anti-microbial resistance seen with mupirocin chemoprophylaxis. RESULTS A total of 101 patients were enrolled, and none were lost to follow up. The incidence of catheter-associated bacteremias in the Medihoney -treated (n=51) and Mupirocin-treated (n=50) were comparable. During the study period 2% of staphylococcal isolates within the hospital were mupirocin resistant. Medihoney Antibacterial Honey and Mupirocin were well tolerated in both groups with no systemic side effects. PUBLISHED CLINICAL TRIALS 2. Patient acceptability and tolerance of Medihoney in the management of non-healing leg ulcers Cheryl Dunford, Salisbury Health Care, UK & Dr. Ralph Hanano, Hartmann. Journal of Wound Care (5): A prospective, descriptive, non-randomised feasibility study involving 4 UK centres to determine whether Medihoney Antibacterial Honey is an acceptable treatment for patients with leg ulcers in terms of pain relief, odour control and overall patient satisfaction. 40 patients with ulcers resistant to twelve weeks of compression were recruited. Medihoney Antibacterial Honey dressings were applied instead of their previous dressings for a 12-week period. All other aspects of care remained unchanged. RESULTS Ulcer pain and size decreased significantly. Odorous wounds were deodorised promptly. Positive impact on patient satisfaction with the Medihoney Antibacterial Honey treatment regime. CONCLUSIONS The results supported the previously reported positive effects of honey and revealed a high patient acceptability for Medihoney Antibacterial Honey treatment. CONCLUSIONS The application of Medihoney Antibacterial Medical Honey to exit sites of tunneled, cuffed haemodialysis catheters was safe, inexpensive and effective and resulted in a comparable rate of catheter-associated infections to that obtained with 2% Mupirocin. The effectiveness of Medihoney Antibacterial Medical Honey against antibiotic-resistant microorganisms and its low likelihood of selecting for further resistant strains suggest that Medihoney Antibacterial Medical Honey may represent a satisfactory, alternative means of preventing haemodialysis catheter infections.
5 CLINICAL RESEARCH PUBLISHED CASE SERIES 1. Wound care with antibacterial honey (Medihoney ) in pediatric hematology oncology. Simon A, Sofka K, Wiszniewsky G, Blaser G, Bode U, Fleischhack G., Department of Pediatric Hematology and Oncology, Children's Hospital, University of Bonn, Germany Supportive Care in Cancer (1): 91-7 Medihoney dressings have now been used for 3 years in wound care at the Department of Pediatric Oncology, Children's Hospital, University of Bonn. This paper presents clinical data from 16 wound care situations in 14 pediatric oncology patients. Most wounds that were treated with Medihoney dressings were dehiscent or infected surgical wounds, drainage sites including MRSA infections as well as secondarily healing deep wounds. Outcomes were sterile wound healing despite immunosuppression. Medihoney dressings were simple, convenient and non-adherent and required minimal cleaning of the wound. This observational study revealed a high acceptability of the Medihoney dressings by both patient and family, having a positive impact on patient and parent satisfaction. CLINICAL TRIALS IN PROGRESS 1. An evaluation of the effectiveness of Antibacterial Wound Gel in the management of chronic ulcers compared to Silvazine, the standard treatment (silver sulphadiazine/ chlorhexidine) Di Smith, Royal Brisbane Hospital, Australia Prospective, randomised controlled study. 65 patients in each arm of the study, 130 patients. PUBLISHED CASE SERIES 2. The Use of Leptospermum Honey (Medihoney ) in Wound Management Randomised clinical trial on 200 patients wounds healing by secondary intention. Val Robson, University Hospital Aintree, UK Prospective, randomised, controlled trial. OBJECTIVES Compare healing rates with Medihoney Antibacterial Honey and conventional wound dressings over 24 week period. Effect Medihoney Antibacterial Honey has on infected or colonised wounds by consistent wound swabbing. PRIMARY OUTCOME MEASURES Number of patients with significant improvement (reduction in size and depth of the wound). Number of patients with complete healing in 24 weeks. 3. An Evaluation of the Use of Medihoney Antibacterial Honey in the Management of Malodorous Wounds Toni Bradley, Palliative Care Service, Prince Charles Hospital, Australia Prospective, randomised, controlled trial on malodorous wounds. 20 patients Medihoney Antibacterial Honey, 20 patients standard dressing. OBJECTIVES To evaluate whether Medihoney Antibacterial Honey is effective in reducing malodour and controlling exudate over a 7 day treatment period. Quality of life improvement. PRIMARY OUTCOME Demonstrate that Medihoney Antibacterial Wound Gel is as effective as Silvazine in reducing the bacterial load present in chronic ulcers. SECONDARY OUTCOMES Improvement in clinical parameters of wound. Improvement in the histopathological and immunological parameters.
6 CLINICAL RESEARCH CLINICAL TRIALS IN PROGRESS CONTINUED 4. Comparative trial on prevention of infection in paediatric burns Prof Heinz Rode, Red Cross Children's Hospital Cape Town, South Africa Prospective, controlled, randomised trial. Standard treatment of SSD (Silver sulphadiazine) vs Medihoney Antibacterial Wound Gel. INCLUSIONS Superficial and partial thickness paediatric burns, less than 72 hours old. Less than 40% Total Body Surface Area. OBJECTIVES Prevention of infection. Time to complete healing. CLINICAL TRIALS COMPLETED 1. The effects of Medihoney Ophthalmic Honey on the ocular surface in dry eye syndrome and eyelid disease and related ocular surface disorders Dr Lee M Lenton, Dr Julie Albietz Ophthalmology Specialist Centre, Brisbane, Australia Single site, prospective, pilot study, non-masked, non-randomised. 80 patients non-responsive or not well controlled with conventional treatments: Non-autoimmune tear deficient dry eye; Sjogren s syndrome (autoimmune dry eye); Chronic eyelid disease. RESULTS The total colony-forming units (CFU) isolated from each of the dry eye groups prior to Medihoney Ophthalmic Honey use were significantly greater than the total CFU control group. Medihoney Ophthalmic Honey use significantly reduced total CFU in the lids and the conjunctiva of dry eye subjects at month 1 and month 3 compared to base line. At month 3 there were reductions in total CFU for all dry eye groups such that the CFUs were not significantly different to those of the control group. CONCLUSIONS Medihoney Ophthalmic Honey helps reduce the signs and symptoms associated with chronic ocular surface damage. Publication: Albietz JM & Lenton LM Effect of Antibacterial Honey on the ocular flora in tear deficiency and meibomian gland disease. Cornea; 25(9):
7 ANTIBACTERIAL WOUND GEL ONE PRODUCT, THREE ACTIONS. WOUND PROTECTION WOUND CLEANING WOUND HEALING MEDIHONEY ANTIBACTERIAL WOUND GEL IS A TOPICAL PREPARATION FOR CHRONIC AND ACUTE WOUND CARE. It has been specially formulated combining 80% Medihoney Antibacterial Honey with natural waxes and oils to provide a high viscosity gel that is easy to apply with good wash off characteristics when dressings are changed. Medihoney Antibacterial Wound Gel is proven to be clinically effective for: Inhibiting bacteria at the wound bed (effective against more than 200 clinical isolates); Fast, effective autolytic debridement on sloughy and necrotic tissue in an antibacterial environment; Rapidly removing malodour; Providing a moist wound healing environment thus reducing trauma and pain at dressing change. INDICATIONS: Surgical wounds Burns Pressure sores Acute & Chronic wounds Leg / foot ulcers Donor and recipient graft sites SUPERIOR WOUND BED PREPARATION: The high osmotic potential created by Medihoney Antibacterial Wound Gel causes a mass flow of bacteria, endotoxins and necrotic material away from the wound bed. This material is then contained in an antibacterial matrix for easy removal at dressing change. MIC OF 127 DRUG-RESISTANT CLINICAL ISOLATES ( ) Narelle George, Qld Health Pathology and Scientific Services, Royal Brisbane Hospital Bacteria MRSA / nm* MRSA ESBL VRE Acinetobacter Pseudomonas aeruginosa Minimum Inhibitory Concentration (MIC). * nm: non-multiresistant Concentration of Medihoney (%) 0% 2% 4% 6% 8% 10% 12% 14% 16% Antibacterial Honey Clinical and In Vitro research has shown that Medihoney Antibacterial Honey at low concentrations is effective against a broad spectrum of bacteria, including antibiotic-resistant strains.
8 THE ORIGINAL WOUND CARE SOLUTION DIRECTIONS FOR USE: Protect wound edges with a barrier cream. Medihoney Antibacterial Wound Gel can be directly applied to the wound bed. Ensure that Medihoney Antibacterial Wound Gel is in full contact with the wound bed (approximately 3mm thickness). A non-adherent gauze dressing should be applied to cover Medihoney Antibacterial Wound Gel. The secondary dressing should be sufficiently absorbent to accommodate the volume of wound exudate. Medihoney Antibacterial Wound Gel can be left on the wound for up to 7 days dependant on the exudate levels. ORDERING INFORMATION: PRODUCT NAME SIZE SHIPPER QTY Medihoney Antibacterial 10G 25 units per box Wound Gel single use tube 20 units per box Medihoney Antibacterial 20G 25 units per box Wound Gel single use tube 20 units per box Medihoney Antibacterial 50G Product Wound Gel re-sealable tube available soon References: 1. Sofka K et al Antibakterieller Honig (Medihoney ) zur Wundpflege - Wundantisepsis bei pädiatrischen Patienten in der Hämatologie-Onkologie? [Antibacterial Honey (Medihoney ) for Woundcare - an antiseptic option for wound care in paediatric oncology?]; Krankenhaus-Hygiene und Infektionsverhütung; 26(5): Simon A et al Wound care with antibacterial honey (Medihoney ) in pediatric hematology oncology. Supportive Care in Cancer; 14(1): Dunford CE & Hanano R Acceptability to patients of a honey dressing for non-healing venous ulcers. J Wound Care; 13(5): George NM Honey antimicrobial agent au naturel. Paper presented at the Australian Infection Control Association Third Biennial Conference, Hobart, June 5. Blair S Honey and Drug Resistant Pathogens. Paper presented at Joint Scientific Meeting of the Australian Society for Microbiology, Cairns, July 6. Lusby PE, Coombes AL, Wilkinson JM Bactericidal activity of different honeys against pathogenic bacteria. Arch Med Research; 36: Wilkinson JM, Cavanagh HMA Antibacterial activity of 13 honeys against Escherichia coli and Pseudomonas aeruginosa. J Med Food; 8(1): Irish J et al Honey has an antifungal effect against Candida species. Med Mycol; 44(3): HEAD OFFICE Comvita New Zealand Ltd Wilson Road South Paengaroa Bay of Plenty 3189 New Zealand NZ Toll Free Facsimile +64 (0) AUSTRALIA Medihoney Pty Ltd BTP Technology & Conference Centre Cnr Miles Platting Rd and Logan Rd Eight Mile Plains QLD 4113 Australia AUST Toll free: Facsimile: +61 (0) EC REP Medihoney (Europe) Ltd The Nova Building Herschel Street, Slough Berkshire SL1 1XS UK UK Toll free: Int Tel: +44 (0) Facsimile: +44 (0) Germany Telephone +49 (0) Facsimile +49 (0)
9 ANTIBACTERIAL MEDICAL HONEY ONE PRODUCT, THREE ACTIONS. WOUND PROTECTION WOUND CLEANING WOUND HEALING MEDIHONEY ANTIBACTERIAL MEDICAL HONEY IS A TOPICAL PREPARATION FOR CHRONIC AND ACUTE WOUND CARE. Medihoney Antibacterial Medical Honey contains 100% Medihoney Antibacterial Honey and is proven to be clinically effective for: Inhibiting bacteria at the wound bed (effective against more than 200 clinical isolates); Fast, effective autolytic debridement on sloughy and necrotic tissue in an antibacterial environment; Rapidly removing malodour; Providing a moist wound healing environment thus reducing trauma and pain at dressing change. INDICATIONS: Deep wounds Necrotic wounds Surgical wounds Sinus wounds Infected wounds Malodorous wounds SUPERIOR WOUND BED PREPARATION: The high osmotic potential created by Medihoney Antibacterial Medical Honey causes a mass flow of bacteria, endotoxins and necrotic material away from the wound bed. This material is then contained in an antibacterial matrix for easy removal at dressing change. MIC OF 127 DRUG-RESISTANT CLINICAL ISOLATES ( ) Narelle George, Qld Health Pathology and Scientific Services, Royal Brisbane Hospital Bacteria MRSA / nm* MRSA ESBL VRE Acinetobacter Pseudomonas aeruginosa Minimum Inhibitory Concentration (MIC). * nm: non-multiresistant Concentration of Medihoney (%) 0% 2% 4% 6% 8% 10% 12% 14% 16% Antibacterial Honey Clinical and In Vitro research has shown that Medihoney Antibacterial Honey at low concentrations is effective against a broad spectrum of bacteria, including antibiotic-resistant strains.
10 THE ORIGINAL WOUND CARE SOLUTION DIRECTIONS FOR USE: Protect wound edges with a barrier cream. Medihoney Antibacterial Medical Honey can be directly applied to the wound bed. A suitable ribbon/cavity dressing may be saturated with Medihoney Antibacterial Medical Honey for use in deep wounds. Ensure that Medihoney Antibacterial Medical Honey is in full contact with the wound bed. (Approximately 3mm thickness). The secondary dressing should be sufficiently absorbent to accommodate the volume of wound exudate. Medihoney Antibacterial Medical Honey can be left on the wound for up to 7 days dependant on the exudate levels. ORDERING INFORMATION: PRODUCT NAME SIZE SHIPPER QTY Medihoney Antibacterial 20G 25 units per box Medical Honey single use tube 20 units per box Medihoney Antibacterial 50G Product Medical Honey re-sealable tube available soon References: 1. Sofka K et al Antibakterieller Honig (Medihoney ) zur Wundpflege - Wundantisepsis bei pädiatrischen Patienten in der Hämatologie-Onkologie? [Antibacterial Honey (Medihoney ) for Woundcare - an antiseptic option for wound care in paediatric oncology?]; Krankenhaus-Hygiene und Infektionsverhütung; 26(5): Simon A et al Wound care with antibacterial honey (Medihoney ) in pediatric hematology oncology. Supportive Care in Cancer; 14(1): Dunford CE & Hanano R Acceptability to patients of a honey dressing for non-healing venous ulcers. J Wound Care; 13(5): George NM Honey antimicrobial agent au naturel. Paper presented at the Australian Infection Control Association Third Biennial Conference, Hobart, June 5. Blair S Honey and Drug Resistant Pathogens. Paper presented at Joint Scientific Meeting of the Australian Society for Microbiology, Cairns, July 6. Lusby PE, Coombes AL, Wilkinson JM Bactericidal activity of different honeys against pathogenic bacteria. Arch Med Research; 36: Wilkinson JM, Cavanagh HMA Antibacterial activity of 13 honeys against Escherichia coli and Pseudomonas aeruginosa. J Med Food; 8(1): Irish J et al Honey has an antifungal effect against Candida species. Med Mycol; 44(3): HEAD OFFICE Comvita New Zealand Ltd Wilson Road South Paengaroa Bay of Plenty 3189 New Zealand NZ Toll Free Facsimile +64 (0) AUSTRALIA Medihoney Pty Ltd BTP Technology & Conference Centre Cnr Miles Platting Rd and Logan Rd Eight Mile Plains QLD 4113 Australia AUST Toll free: Facsimile: +61 (0) EC REP Medihoney (Europe) Ltd The Nova Building Herschel Street, Slough Berkshire SL1 1XS UK UK Toll free: Int Tel: +44 (0) Facsimile: +44 (0) Germany Telephone +49 (0) Facsimile +49 (0)
11 BARRIER CREAM Medihoney Barrier Cream helps maintain the skin s barrier properties and maintain skin moisture and ph. Suitable for wet areas* Helps maintain ph of the skin Contains 30% Medihoney Antibacterial Honey *Medihoney Barrier Cream can be applied to intact and at-risk skin to provide protection from body fluids and moisture. It can be applied around wounds and under skin folds, wound dressings and incontinence pads where a protective barrier will help prevent skin breakdown. INDICATIONS FOR USE Protects at-risk skin from breakdown associated with incontinence and can be used under incontinence pads Can be used around wound edges to protect the skin from irritation or breakdown caused by wound exudate Helps protect the skin from damage caused by friction or shear Helps prevent maceration Helps prevent excoriation Helps maintain the skin ph Helps prevent damage to skin caused by frequent hand washing SPECIALLY FORMULATED Medihoney Barrier Cream is specially formulated with a range of natural ingredients and NO Added colour or fragrance NO Lanolin NO Parabens NO Steroids NO Mineral Oils DIRECTIONS FOR USE Apply to clean, dry skin three times a day or as required. Reapply after bathing or at each dressing change. Suitable for use on children. PRECAUTIONS When using for the first time, patch test on a small area of skin. If irritation occurs discontinue use. ORDERING INFORMATION PRODUCT NAME SIZE SHIPPER QTY Medihoney 50g resealable 24 units Barrier Cream tube per box
12 FIRST CHOICE IN SKIN AND WOUND CARE THE SKIN Normal skin has a naturally acidic protective mantle. The acid mantle helps to hydrate the skin by protecting it from drying and from harmful bacteria. Skin ailments such as eczema and dermatitis are linked to a disrupted acid mantle with subsequent colonisation by bacteria such as Staphylococcus aureus. The use of Medihoney Barrier Cream helps maintain the skin's protective ph. In vitro studies have shown Staphylococcus aureus to be one of the most sensitive bacteria to Medihoney s Antibacterial Honey. Medihoney Barrier Cream contains 30% Medihoney Antibacterial Honey which is proven to be effective against a range of microorganisms. MEDIHONEY ANTIBACTERIAL HONEY Medihoney wound care and skin care products contain medical grade Antibacterial Honey. Advanced biomedical research by Medihoney has identified specific plants that produce honey with exceptional antibacterial activity. The antibacterial activity of honey differs according to the plant species and may vary enormously within any one species. Medihoney Antibacterial Honey is a standardised antibacterial honey, predominantly Leptospermum sp. selected for its broad range of antibacterial actions. In 2007, the journal Wounds featured an article that evaluated the in vitro activity of Medihoney Antibacterial Honey against a challenge set of 127 clinical isolates with multiple antibiotic resistance. The study showed that the Medihoney Antibacterial Honey was effective at inhibiting these bacteria irrespective of their level of antibiotic resistance. Particularly effective against Staphylococcus aureus and MRSA down to a 4% dilution 1. MIC OF 127 DRUG-RESISTANT CLINICAL ISOLATES ( ) Narelle George, Qld Health Pathology and Scientific Services, Royal Brisbane Hospital * nm: non-multiresistant Bacteria Minimum Inhibitory Concentration (MIC). MRSA / nm* MRSA ESBL VRE Acinetobacter Pseudomonas aeruginosa Concentration of Medihoney (%) Antibacterial Honey 0% 2% 4% 6% 8% 10% 12% 14% 16% References: 1. George NM & Cutting K F Antibacterial Honey (Medihoney ): in-vitro Activity Against Clinical Isolates of MRSA, VRE, and Other Multiresistant Gram-negative Organisms Including Pseudomonas aeroginosa. J Wounds; 19(9): Taskapan MO & Kumar P Role of staphylococcal superantigens in atopic dermatitis: from colonisation to inflammation. Annals of Allergy, Asthma, & Immunology; 84(1): 3-10 HEAD OFFICE Comvita New Zealand Ltd Wilson Road South Paengaroa Bay of Plenty 3189 New Zealand NZ Toll Free Facsimile +64 (0) AUSTRALIA Medihoney Pty Ltd BTP Technology & Conference Centre Cnr Miles Platting Rd and Logan Rd Eight Mile Plains QLD 4113 Australia AUST Toll free: Facsimile: +61 (0) EC REP Medihoney (Europe) Ltd The Nova Building Herschel Street, Slough Berkshire SL1 1XS UK UK Toll free: Int Tel: +44 (0) Facsimile: +44 (0) Germany Telephone +49 (0) Facsimile +49 (0)
13 DERMA CREAM Medihoney Derma Cream helps to protect vulnerable skin and moisturise dry skin conditions. Suitable for dry areas* Helps maintain ph of the skin Contains 30% Medihoney Antibacterial Honey *Medihoney Derma Cream can be used on large skin areas and under compression or wound dressings to protect intact skin from breakdown and irritation caused by dryness, friction or shear. INDICATIONS FOR USE Protects intact, vulnerable or at-risk skin from breakdown Helps maintain the skin s properties and maintain skin moisture Helps protect the skin from irritation or breakdown caused by dryness, friction or shear Helps maintain the skin ph Helps prevent folliculitis Helps reduce itching SPECIALLY FORMULATED Medihoney Derma Cream is specially formulated with a range of natural ingredients and NO Added colour or fragrance NO Lanolin NO Parabens NO Steroids NO Mineral Oils DIRECTIONS FOR USE Apply to clean, dry skin three times a day or as required. Reapply after bathing or at each dressing change. Suitable for use on children. PRECAUTIONS When using for the first time, patch test on a small area of skin. If irritation occurs discontinue use. ORDERING INFORMATION PRODUCT NAME SIZE SHIPPER QTY Medihoney 50g resealable 24 units Derma Cream tube per box
14 FIRST CHOICE IN SKIN AND WOUND CARE THE SKIN Normal skin has a naturally acidic protective mantle. The acid mantle helps to hydrate the skin by protecting it from drying and from harmful bacteria. Skin ailments such as eczema and dermatitis are linked to a disrupted acid mantle with subsequent colonisation by bacteria such as Staphylococcus aureus. The use of Medihoney Derma Cream helps maintain the skin's protective ph. In vitro studies have shown Staphylococcus aureus to be one of the most sensitive bacteria to Medihoney s Antibacterial Honey. Medihoney Derma Cream contains 30% Medihoney Antibacterial Honey which is proven to be effective against a range of microorganisms. MEDIHONEY ANTIBACTERIAL HONEY Medihoney wound care and skin care products contain medical grade Antibacterial Honey. Advanced biomedical research by Medihoney has identified specific plants that produce honey with exceptional antibacterial activity. The antibacterial activity of honey differs according to the plant species and may vary enormously within any one species. Medihoney Antibacterial Honey is a standardised antibacterial honey, predominantly Leptospermum sp. selected for its broad range of antibacterial actions. In 2007, the journal Wounds featured an article that evaluated the in vitro activity of Medihoney Antibacterial Honey against a challenge set of 127 clinical isolates with multiple antibiotic resistance. The study showed that the Medihoney Antibacterial Honey was effective at inhibiting these bacteria irrespective of their level of antibiotic resistance. Particularly effective against Staphylococcus aureus and MRSA down to a 4% dilution 1. MIC OF 127 DRUG-RESISTANT CLINICAL ISOLATES ( ) Narelle George, Qld Health Pathology and Scientific Services, Royal Brisbane Hospital * nm: non-multiresistant Bacteria Minimum Inhibitory Concentration (MIC). MRSA / nm* MRSA ESBL VRE Acinetobacter Pseudomonas aeruginosa Concentration of Medihoney (%) Antibacterial Honey 0% 2% 4% 6% 8% 10% 12% 14% 16% References: 1. George NM & Cutting K F Antibacterial Honey (Medihoney ): in-vitro Activity Against Clinical Isolates of MRSA, VRE, and Other Multiresistant Gram-negative Organisms Including Pseudomonas aeroginosa. J Wounds; 19(9): Taskapan MO & Kumar P Role of staphylococcal superantigens in atopic dermatitis: from colonisation to inflammation. Annals of Allergy, Asthma, & Immunology; 84(1): 3-10 HEAD OFFICE Comvita New Zealand Ltd Wilson Road South Paengaroa Bay of Plenty 3189 New Zealand NZ Toll Free Facsimile +64 (0) AUSTRALIA Medihoney Pty Ltd BTP Technology & Conference Centre Cnr Miles Platting Rd and Logan Rd Eight Mile Plains QLD 4113 Australia AUST Toll free: Facsimile: +61 (0) EC REP Medihoney (Europe) Ltd The Nova Building Herschel Street, Slough Berkshire SL1 1XS UK UK Toll free: Int Tel: +44 (0) Facsimile: +44 (0) Germany Telephone +49 (0) Facsimile +49 (0)
15 WOUND CARE & PRODUCT SELECTION CHART WOUND TYPE TREATMENT OBJECTIVE PRODUCT SELECTION MODE OF ACTION PRECAUTIONS BLACK, DRY, NECROTIC Rehydrate Debride Wound protection ANTIBACTERIAL WOUND GEL ANTIBACTERIAL MEDICAL HONEY The osmotic action produces an outflow of body fluid helping to lift debris and remove necrotic tissue. The moist wound environment reduces the risk of eschar formation. Provides an antibacterial environment that helps protect the wound. Diabetic and arterial wounds should be managed under clinical care. Protect Wound edges with Medihoney Barrier Cream YELLOW, SLOUGHY Remove slough Rehydrate Wound protection Manage exudate ANTIBACTERIAL WOUND GEL The high osmotic potential of Antibacterial Wound Gel causes a mass flow of bacteria, endotoxins and sloughy material away from the wound bed. This material is then contained in an antibacterial matrix for easy removal at dressing change. Ensure secondary dressing is sufficiently absorbent to accommodate exudate. Protect wound edges with Medihoney Barrier Cream. RED, GRANULATION Maintain moist wound bed Assist wound healing Wound protection Manage exudate ANTIBACTERIAL WOUND GEL Osmotic action brings fluid into the wound providing a moist wound environment to assist the granulation process. Waxes provide a protective coating over the wound, reducing trauma on dressing removal. Antibacterial barrier protects the wound from infection by bacteria. Ensure secondary dressing is sufficiently absorbent to accommodate exudate. Protect wound edges with Medihoney Barrier Cream. PINK, EPITHELIAL Maintain moist wound bed Wound protection Assists wound healing ANTIBACTERIAL WOUND GEL MEDIHONEY MOISTURISING CREAM Provides moist wound environment to encourage the epithelialisation process. Waxes provide a protective coating over the wound, reducing trauma on dressing removal. Antibacterial barrier to protect the wound from contamination and reduces risk of colonisation. INFECTED Reduce infection and colonisation Assist wound healing Clean wound ANTIBACTERIAL WOUND GEL High osmotic potential helps clean the wound and disperse biofilms. Cleaning the wound reduces bacteria loadings, which are a source of inflammatory endotoxins. Provides an antibacterial barrier to protect the wound bed. Protect wound edges with Medihoney Barrier Cream. Clinical care program associated with infected wounds should be followed. CAVITY OR SINUS Aid granulation Assist wound healing Wound protection ANTIBACTERIAL MEDICAL HONEY Absorbs exudate and protects exposed tissue from infecting bacteria, reducing the risk of colonisation. A suitable ribbon/cavity dressing may be saturated with Antibacterial Medical Honey MALODOROUS Remove malodour ANTIBACTERIAL WOUND GEL ANTIBACTERIAL MEDICAL HONEY Inhibits the bacteria that cause odour. Helps clean the wound and lift debris to rapidly reduce odour. PRODUCT SIZE HOSPITAL / PHARMACY NHS LOGISTICS AUTHORITY AVAILABLE QTY CODE QTY CODE ON FP10 Medihoney Antibacterial Medical Honey 20g 1 single use tube PIP box of 20 tubes ELZ015 YES Medihoney Antibacterial Wound Gel 10g 1 single use tube PIP box of 20 tubes ELZ013 YES 20g 1 single use tube PIP box of 20 tubes ELZ014 YES HEAD OFFICE Medihoney Pty Ltd 399 Archerfield Road, PO Box 66, Richlands Qld Australia 4077 Tel: +61 (0) AUS Toll Free Fax: +61 (0) EUROPE Medihoney (Europe) Ltd 200 Brook Drive, Green Park, Reading Berkshire RG2 6UB United Kingdom Tel: +44 (0) UK Toll Free Fax: +44 (0) Germany Tel: +49 (0) Fax:+49 (0) info@medihoney.com
16 THE ORIGINAL WOUND CARE SOLUTION ADVANCED WOUND CARE Medihoney wound care and skin care products contain a uniquely formulated medical grade Antibacterial Honey. Medihoney Antibacterial Medical Honey dressing contains 100% Antibacterial Honey whereas Medihoney Antibacterial Wound Gel contains 80% Antibacterial Honey. Skin care products contain 30% Antibacterial Honey. Medihoney s products use the powerful inhibitory action of Medihoney s Antibacterial Honey to protect wounds from infection; The natural cleaning action of Medihoney s wound care products helps clean wounds of sloughy and necrotic tissue; The strong deodorising action of Medihoney s wound care products rapidly eliminates unpleasant smells from wounds; The low ph of honey helps control protease activity. ANTIBACTERIAL PROTECTION Medihoney s Antibacterial Honey has been independently screened against over 200 clinical isolates. 1,2,3,4,5 Staphylococcus aureus, including drug resistant strains, is inhibited by Medihoney Antibacterial Honey even after a 25 fold dilution. The yeasts Candida albicans, Zygosaccharomyces rouxii and the fungus Aspergillus Niger are also inhibited by Medihoney Antibacterial Honey. WOUND CLEANING Wound cleaning products are designed to provide a moist wound environment, rehydrate necrotic tissue and support autolytic debridement and slough removal. The use of these products can be limited by the possibility of bacteria overgrowth. Medihoney s wound care products have high osmotic potential, natural hydrolytic enzymes and inhibit bacterial growth. The high osmotic potential gives Medihoney wound care products a capacity for absorption. Combined with the benefit of the antibacterial properties to help protect the wounds from colonising bacteria, Medihoney wound care products help clean necrotic and sloughy wounds and contain bacterial growth. ANTIBACTERIAL BARRIER AND ODOUR CONTROL Excess microbial growth in the wound is responsible for unpleasant odours. The judicious use of an antibacterial barrier to protect wounds from bacterial growth is advantageous in reducing odour. The antibacterial activity of the honey used by Medihoney Antibacterial Honey has been assessed against most common wound infecting organisms including antibiotic resistant strains. PROTEASE INHIBITION Proteases are enzymes that play an essential role in epithelialisation by facilitating the removal of damaged components and assisting in the restructure of the basement membrane. If the expression of protease is uncontrolled, damage to the extracellular matrix and prevention of the migration and attachment of keratinocytes can occur, adversely impacting on the healing process. Protease activity may also adversely affect important growth factors. Peak protease enzyme activity occurs at ph 7 to ph 9. The ph of chronic wounds varies between 5.5 and 8.7. Adjustment of the wound environment to a ph below 6 may help reduce proteolytic activity. 6 Medihoney wound care products have a low ph. The ph is also strongly buffered by the natural production of gluconic acid. If the antibacterial honey is diluted, glucose is converted into gluconic acid and hydrogen peroxide, maintaing a low ph. The low ph wound environment created by Medihoney Antibacterial Honey application will therefore assist the healing process of chronic wounds. 1. George NM Honey antimicrobial agent au naturel. Paper presented at the Australian Infection Control Association Third Biennial Conference, Hobart, June 2. Blair S Honey and Drug Resistant Pathogens. Paper presented at Joint Scientific Meeting of the Australian Society for Microbiology, Cairns, July 3. Irish J et al Honey has an antifungal effect against Candida species. Med Mycol; 44(3): Lusby PE, Coombes AL, Wilkinson JM Bactericidal activity of different honeys against pathogenic bacteria. Arch Med Research; 36: Wilkinson JM, Cavanagh HMA Antibacterial activity of 13 honeys against Escherichia coli and Pseudomonas aeruginosa. J Med Food; 8(1): Greener B et al Proteases and ph in chronic wounds. J Wound Care; 14(2): 59-61
17 TECHNICAL INFORMATION ADVANCED WOUND CARE Medihoney wound care and skin care products contain a uniquely formulated medical grade Antibacterial Honey. Medihoney Antibacterial Medical Honey contains 100% Antibacterial Honey whereas Medihoney Antibacterial Wound Gel contains 80% Antibacterial Honey. Skin care products contain 30% Antibacterial Honey. Advanced biomedical research by Medihoney has identified specific plants that produce honey with exceptional antibacterial activity. The antibacterial activity of honey differs according to the plant species and may vary enormously within any one species. Medihoney Antibacterial Honey is made up of honey from Leptospermum sp. and several other plant species to benefit from a broad range of antibacterial action. Medihoney grades each Antibacterial Honey using a validated testing procedure conducted by a NATA (National Association of Testing Authorities) accredited laboratory. In association with the Institute of Molecular BioScience we monitor the chemical fingerprint of the honeys used to help standardise for consistency. Medihoney s Antibacterial Honey has been independently screened against over 200 clinical isolates. 1,2,3,4,5 Staphylococcus aureus, including drug resistant strains, is inhibited by Medihoney Antibacterial Honey even after a 25 fold dilution. The yeasts Candida albicans, Zygosaccharomyces rouxii and the fungus Aspergillus Niger are also inhibited by Medihoney Antibacterial Honey. Medihoney s products use the powerful inhibitory action of Medihoney s Antibacterial Honey to protect wounds from infection; 6 The natural cleaning action of Medihoney s wound care products helps clean wounds of sloughy and necrotic tissue; 7 The strong deodorising action of Medihoney s wound care products rapidly eliminates unpleasant smells from wounds; 8 The low ph of honey helps control protease activity. BACKGROUND ON MEDIHONEY ANTIBACTERIAL HONEY In the Australian flora there are more than 25,000 species of plants grouped into around 2,700 genera 9. Most of the modern Australian flora had its origin in the Cretaceous period while Australia was a part of Gondwana. This rich floral diversity provides hundreds of species of plants that produce nectar in sufficient quantity to be of benefit to the bees, giving Australia one of the richest varieties of different honeys of any continent. Each plant species produces honey with a unique chemical composition, referred to as its chemical fingerprint. One plant genus, Leptospermum, which originated on the east coast of Australia 10, can produce honey that has an exceptional antibacterial activity. Current biomedical research has shown that the antibacterial action of honey from Leptospermum sp at low concentrations is more stable than the antibacterial action in honey from any other plant (Medihoney Antibacterial Honey is substantially based on honey from Leptospermum sp.). The genus Leptospermum, of which there are over 80 species, dispersed relatively recently from Eastern Australia to New Zealand, New Guinea, and South East Asia 10. The unique antibacterial activity is not consistent and varies enormously. It has only been found in Leptospermum sp. growing in Australia and one Leptospermum sp. growing in New Zealand. By percent of composition the major components of honey are the sugars: fructose, glucose, sucrose and sugar polymers. The ratio of sugars depends on hydrolytic activity of natural enzymes in honey. In addition honey contains acids with the average ph being 3.9. Gluconic acid is the principal acid of honey. It is produced by the action on glucose of the enzyme glucose oxidase and produces hydrogen peroxide. This action is very slow in pure honey but rapid when the honey is diluted. glucose + water + O gluconic 2 acid glucose oxidase + hydrogen peroxide There are many other acids known to exist in honey. Some of these acids are known to have antimicrobial properties but their presence is variable. In addition honey is composed of a comprehensive range of lesser compounds, some have yet to be fully characterised. Their presence is also variable and dependent amongst other things on the plant source of the honey. ANTIBACTERIAL ACTIVITY An important attribute of the unique blend of honeys used in Medihoney s wound care products is their natural antibacterial activity and effectiveness in inhibiting drug resistant bacteria such as Methicillin resistant Staphylococcus aureus (MRSA). When honey is applied to the wound bed, gradual dilution occurs at the wound bed/honey interface. The antibacterial honey used in Medihoney wound care products differs from most other honeys in that it maintains its antibacterial activity even when substantially diluted.
18 ANTIBACTERIAL ACTIVITY CONTINUED In 2004 an Australian State Government Health Pathology and Scientific Services Department evaluated the in vitro activity of Medihoney Antibacterial Honey against a challenge set of 127 clinical isolates with multiple antibiotic resistance. These organisms comprised of: 20 strains of Methicillin Resistant Staphylococcus aureus (MRSA), 28 strains of Non-Multiresistant Methicillin Resistant Staphylococcus aureus (nmmrsa), 20 vancomycin resistant enterococci (VRE), 28 extended spectrum beta-lactamases producing strains (ESBL is an enzyme produced by some bacteria which breaks down certain types of antibiotics.), 20 Pseudomonas aeruginosa and 11 Acinetobacter baumanni. The study showed that the Medihoney Antibacterial Honey was effective at inhibiting these bacteria irrespective of their level of antibiotic resistance. All test strains of MRSA were inhibited at concentrations of 4% v/v. VRE were inhibited at concentrations between 6-8% depending upon the species. ESBL producing gram negative bacteria were inhibited at 6-8% v/v irrespective of the species tested. Pseudomonas aeruginosa was inhibited at between 12 and 14% v/v and 11 multi-resistant Acinetobacter baumanni were inhibited at concentrations of 8% v/v. PROTEASE INHIBITION Proteases are enzymes that play an essential role in epithelialisation by facilitating the removal of damaged components and assisting in the restructure of the basement membrane. If the expression of protease is uncontrolled, damage to the extracellular matrix and prevention of the migration and attachment of keratinocytes can occur, adversely impacting on the healing process. Protease activity may also adversely affect important growth factors. Peak protease enzyme activity occurs at ph 7 to ph 9. The ph of chronic wounds varies between 5.5 and 8.7. Adjustment of the wound environment to a ph below 6 may help reduce the proteolytic activity 11. Medihoney wound care products have a low ph. The ph is also strongly buffered by the natural production of gluconic acid. If the Medihoney Antibacterial Honey is diluted, glucose is converted into gluconic acid and hydrogen peroxide, maintaing a low ph. The low ph wound environment created by Medihoney Antibacterial Honey application will therefore assist the healing process of chronic wounds. WOUND CLEANING Wound cleaning dressings are designed to provide a moist wound environment, rehydrate necrotic tissue and support autolytic debridement and slough removal. The use of these products can be limited by the possibility of bacteria overgrowth. Medihoney s wound care products have high osmotic potential, natural hydrolytic enzymes and inhibit bacterial growth. The high osmotic potential gives Medihoney wound care products a capacity for absorption. Combined with the benefit of the antibacterial properties to help protect the wounds from colonising bacteria, Medihoney wound care products help clean necrotic and sloughy wounds and contain bacterial growth. ANTIBACTERIAL BARRIER AND ODOUR-CONTROL It is generally agreed that excess microbial growth in the wound may lead to excess inflammatory cell activity and consequential delays in wound healing. Bacteria in heavily colonised wounds are also responsible for unpleasant odours. The judicious use of an antibacterial barrier to protect wounds from bacterial growth is advantageous in reducing odour. The antibacterial activity of the honey used by Medihoney Antibacterial Honey has been assessed against most common wound infecting organisms including antibiotic resistant strains. These organisms were inhibited in a range of 4% - 15% Medihoney Antibacterial Honey. REDUCE DEPENDENCE ON TOPICAL ANTIMICROBIAL PRODUCTS Expert Advisory Committees on Antimicrobial Resistance are highlighting a concern that the misuse of antibiotics could render these drugs useless. The increasing prevalence of antibiotic resistant bacteria, especially those with multiple resistances, is causing international concern. Antibiotic resistance makes infections more difficult to treat, increases the length and severity of illness, the period of infectiousness, adverse reactions (due to the need to use less safe alternative drugs), length of hospital admission and costs 12. The prophylactic use of antibiotics has been shown to significantly reduce infection rates. However the use of antibiotics in this manner leads to the selection of antibiotic resistant bacteria. In a recently published randomised trial comparing Medihoney Antibacterial Honey against Mupirocin as a prophylactic for the prevention of catheter associated infections, the authors noted that the Medihoney Antibacterial Honey was safe, cheap and effective and did not select for antibiotic resistant strains 6. Given the evidence to date on the properties of the antibacterial honey used in Medihoney products, and its equivalence to a leading antibiotic when used as a prophylactic to protect wounds, Medihoney wound care products are ideally suited to reduce the dependence on topical antibiotics. SKIN PROTECTION Medihoney barrier creams and moisturising creams contain 30% Medihoney Antibacterial Honey and natural oils to protect and moisturise the skin. Some common bacteria can aggravate atopic dermatitis. Super-antigens from Staphylococcus aureus may be an important triggering factor in atopic dermatitis 13. In vitro studies have shown Staphylococcus aureus to be one of the most sensitive bacteria to Medihoney s Antibacterial Honey. Use of Medihoney creams helps protect the skin from these colonising bacteria. 1. George NM Honey antimicrobial agent au naturel. Paper presented at the Australian Infection Control Association Third Biennial Conference, Hobart, June 2. Blair S Honey and Drug Resistant Pathogens. Paper presented at Joint Scientific Meeting of the Australian Society for Microbiology, Cairns, July 3. Irish J et al Honey has an antifungal effect against Candida species. Med Mycol; 44(3): Lusby PE, Coombes AL, Wilkinson JM Bactericidal activity of different honeys against pathogenic bacteria. Arch Med Research; 36: Wilkinson JM, Cavanagh HMA Antibacterial activity of 13 honeys against Escherichia coli and Pseudomonas aeruginosa. J Med Food; 8(1): Johnson DW et al Randomised controlled trial of topical exit-site application of honey (Medihoney ) versus Mupirocin for the prevention of catheter-associated infections in haemodialysis patients. J Am Soc Nephrol; 16(5): White R and Acton C Honey in modern wound management. MIMS Dermatology; 2(1): Dunford C and Hanano R Acceptability to patients of a honey dressing for non-healing venous leg ulcers. Journal of Wound Care; 13(5): Thiele KR & Adams LG (eds) Families of Flowering Plants of Australia. CSIRO Publishing / Australian Biological Resources Study (ABRS), Melbourne 10. Thompson J A revision of the genus Leptospermum (Myrtaceae). Telopea; 3(3): Greener B et al Proteases and ph in chronic wounds. J Wound Care; 14(2): Specialist Advisory Committee on Antimicrobial Resistance UK Antimicrobial Resistance Strategy and Action Plan. UK Department of Health 13. Taskapan MO & Kumar P Role of staphylococcal superantigens in atopic dermatitis: from colonisation to inflammation. Annals of Allergy, Asthma, & Immunology; 84(1): 3-10
Val Robson University Hospital Aintree. Liverpool U.K.
Val Robson University Hospital Aintree. Liverpool U.K. Results of a Randomised Controlled Trial Comparing Antibacterial Honey (Medihoney ) to conventional treatment in wound care and the problems arising
More informationLet's get physical: Cutimed Sorbact
Let's get physical: Cutimed Sorbact Staph. aureus (yellow), Pseudomonas aeruginosa (purple), Enterococcus faecalis (blue), Klebsiella spec. (green) and Candida albicans (orange) bound to Cutimed Sorbact
More informationOpticell Wound Dressings. Powerful Yet Gentle Moisture Management
Wound Dressings Powerful Yet Gentle Moisture Management 1 Exclusive Forzagel TM Technology s unique gelling attributes are the result of Forzagel technology. When moistened, the absorbent fibers of the
More informationWhat dressing for what wound. Prudence Lennox National Clinical Leader Healthcare Rehabilitation Ltd
What dressing for what wound Prudence Lennox National Clinical Leader Healthcare Rehabilitation Ltd Wound assessment Accurate wound assessment is a prerequisite to planning appropriate care & should adopt
More informationTAKING CARE OF WOUNDS KEY FIGURE:
Chapter 9 TAKING CARE OF WOUNDS KEY FIGURE: Gauze Wound care represents a major area of concern for the rural health provider. This chapter discusses the treatment of open wounds, with emphasis on dressing
More informationWound Care: The Basics
Wound Care: The Basics Suzann Williams-Rosenthal, RN, MSN, WOC, GNP Norma Branham, RN, MSN, WOC, GNP University of Virginia May, 2010 What Type of Wound is it? How long has it been there? Acute-generally
More informationDevelopment of a Next- Generation Antimicrobial Wound Dressing- Results Count
Development of a Next- Generation Antimicrobial Wound Dressing- Results Count Phil Bowler, MPhil, FIBMS Science & Technology, ConvaTec 24 th November 2015 /TM all trade marks are the property of their
More informationMicrocyn Technology. Life-Altering Advance in Tissue Care
Microcyn Technology Life-Altering Advance in Tissue Care The patented Microcyn Technology mimics the same oxychlorine composition as that manufactured by neutrophils in the body s immune system. Neutrophils
More informationAn evaluation of Actilite Antibacterial non-adherent dressing with Activon+
An evaluation of Actilite Antibacterial non-adherent dressing with Activon+ Antibacterial protection Activon honey plus Manuka oil. Non-adherent The non-adherence of the knitted viscose is further enhanced
More informationManaging cavity wounds Journal of Community Nursing March 1998 Author: Rosemary Pudner
Managing cavity wounds Journal of Community Nursing March 1998 Author: Rosemary Pudner It has been seen in recent years, that an increasing number of patients are being discharged early into the community,
More informationSummary of Recommendations
Summary of Recommendations *LEVEL OF EVIDENCE Practice Recommendations Assessment 1.1 Conduct a history and focused physical assessment. IV 1.2 Conduct a psychosocial assessment to determine the client
More informationThe compatibility of INTRASITE Gel and ACTICOAT : An In-Vivo and In-Vitro assessment
*smith&nephew The compatibility of INTRASITE Gel and ACTICOAT : An In-Vivo and In-Vitro assessment 1 Trade Marks of Smith & Nephew An In-Vivo and In-Vitro assessment of the compatibility of ACTICOAT and
More informationWound Care on the Field. Objectives
Wound Care on the Field Brittany Witte, PT, DPT Cook Children s Medical Center Objectives Name 3 different types of wounds commonly seen in sports and how to emergently provide care for them. Name all
More informationWound and Skin Assessment. Mary Carvalho RN, BSN, MBA Clinical Coordinator Johnson Creek Wound and Edema Center
Wound and Skin Assessment Mary Carvalho RN, BSN, MBA Clinical Coordinator Johnson Creek Wound and Edema Center Skin The largest Organ Weighs between 6 and 8 pounds Covers over 20 square feet Thickness
More informationThe role of MEDIHONEY in treating acute and chronic wounds of our nation s military
The role of MEDIHONEY in treating acute and chronic wounds of our nation s military Kara S. Couch, MS, CRNP, CWS Complex Wound and Limb Salvage Center Bethesda, MD Agenda My clinical practice Why MEDIHONEY?
More informationSuper-absorbent dressing for improving patient care
BIGGER PACKAGES NOW AVAILABLE! Super-absorbent dressing for improving patient care BRITAIN S No. SUPER-ABSORBENT (IMS May 205) Caring with KerraMax As a woundcare nurse, you ve seen the damage exudate
More informationMethicillin Resistant Staphylococcus aureus (MRSA) in Tasmanian Rural Hospitals and Non Acute Health Settings
Methicillin Resistant Staphylococcus aureus (MRSA) in Tasmanian Rural Hospitals and Non Acute Health Settings Guidance for the management of patients with MRSA in Tasmania's rural hospitals and non acute
More information3.0 Treatment of Infection
3.0 Treatment of Infection Antibiotics and Medicine National Curriculum Link SCN 3-13b SCN 3-20b HWB 3-15a HWB 3-16a HWB 3-17a Learning Outcomes All students will know: Most common infections will get
More informationCOMPLIANCE WITH THIS DOCUMENT IS MANDATORY
COVER SHEET NAME OF DOCUMENT Wound Wound Assessment and Management TYPE OF DOCUMENT Procedure DOCUMENT NUMBER SESLHDPR/297 DATE OF PUBLICATION April 2014 RISK RATING Medium LEVEL OF EVIDENCE N/A REVIEW
More informationLaboratory Exercise # 11: Differentiation of the Species Staphylococcus and Streptococcus
Laboratory Exercise # 11: Differentiation of the Species Staphylococcus and Streptococcus Purpose: The purpose of this laboratory exercise is to explore the differences between Staphylococcal species and
More informationHand Dermatitis in Health Care Workers
Hand in Health Care Workers Safety and Health Assessment and Research for Prevention (SHARP) Program Washington Department of Labor and Industries PO Box 44330 Olympia, WA 98504-4330 1-888-66-SHARP www.lni.wa.gov/sharp/derm
More informationPressure Ulcers: Facility Assessment Checklists
Pressure Ulcers: Facility Assessment Checklists This is a series of self-assessment checklists for nursing home staff to use to assess processes related to managing pressure ulcers in the facility, in
More informationPressure Ulcers Risk Management and Treatment
Pressure Ulcers Risk Management and Treatment Objectives State reasons why individuals initiate lawsuits. Define strategies to reduce the risk of litigation. Determine appropriate treatment for the patient.
More informationWound Classification Name That Wound Sheridan, WY June 8 th 2013
Initial Wound Care Consult Sheridan, WY June 8 th, 2013 History Physical Examination Detailed examination of the wound Photographs Cultures Procedures TCOM ABI Debridement Management Decisions A Detailed
More informationPosition Statement: Pressure Ulcer Staging
Position Statement: Pressure Ulcer Staging Statement of Position The Wound, Ostomy and Continence Nurses (WOCN) Society supports the use of the National Pressure Ulcer Advisory Panel Staging System (NPUAP).
More informationWound Healing. Healing is a matter of time, but it is sometimes also a matter of opportunity. Hippocrates
C HAPTER 9 Wound Healing Healing is a matter of time, but it is sometimes also a matter of opportunity. Hippocrates As the above quote suggests, conduct regular and systematic wound assessments, and seize
More informationAPPLICATION OF DRY DRESSING
G-100 APPLICATION OF DRY DRESSING PURPOSE To aid in the management of a wound with minimal drainage. To protect the wound from injury, prevent introduction of bacteria, reduce discomfort, and assist with
More informationPolicy for Screening Patients for MRSA Colonisation
Policy for Screening Patients for MRSA Colonisation To whom this document applies: All staff in Colchester Hospital University Foundation Trust screening Patients for MRSA Procedural Documents Approval
More informationThe true cost of wounds. And how to reduce it
The true cost of wounds And how to reduce it Wounds are a growing challenge Wounds have been called the silent epidemic. In a typical hospital setting today, between 25% and 40% of beds will be occupied
More informationCOMMON BACTERIAL SKIN INFECTIONS IN GENERAL PRACTICE
COMMON BACTERIAL SKIN INFECTIONS IN GENERAL PRACTICE The two most common bacteria to cause skin infections are staphylococcus aureus (staph aureus ) and streptococcus pyogenes ( strep) (see Table 1). Staphylococcus
More informationTHICKER GEL GENERATES MORE IODINE
THICKER GEL GENERATES MORE IODINE Hydrogen peroxide More Iodide Thicker Gel Oxygen More Iodine IODOZYME HAS SIGNIFICANTLY LOWER IODINE LEVELS THAN CONVENTIONAL IODINE DRESSINGS Free iodine (I -& I ) concentration/
More informationUTILIZATION of PLASMA ACTIVATED WATER in Biotechnology, Pharmacology and Medicine. JSC TECHNOSYSTEM-ECO Moscow, Russia April, 2009
UTILIZATION of PLASMA ACTIVATED WATER in Biotechnology, Pharmacology and Medicine JSC TECHNOSYSTEM-ECO Moscow, Russia April, 2009 METHOD of WATER ACTIVATION with PLASMA of GAS DISCHARGE ANODE VACUUM WATER
More informationWOUND MANAGEMENT PROTOCOLS WOUND CLEANSING: REMOVING WOUND DEBRIS FROM WOUND BASE
WOUND MANAGEMENT PROTOCOLS PURPOSE: Provide nursing personnel with simple guidance regarding appropriate dressing selection in the absence of wound specialist expertise Identify appropriate interventions
More informationMicroSilver BG TM. The innovative agent for beautiful, healthy skin.
The innovative agent for beautiful, healthy skin. Inhalt Why MicroSilver BG TM? 3 What is MicroSilver BG TM? 3 How does MicroSilver BG TM work? 3 Products and usage 4 MicroSilver BG TM still used today
More informationFUNCTIONS OF THE SKIN
FUNCTIONS OF THE SKIN Skin is the largest organ of the body. The average adult has 18 square feet of skin which account for 16% of the total body weight. Skin acts as a physical barrier for you to the
More informationNursing college, Second stage Microbiology Dr.Nada Khazal K. Hendi L14: Hospital acquired infection, nosocomial infection
L14: Hospital acquired infection, nosocomial infection Definition A hospital acquired infection, also called a nosocomial infection, is an infection that first appears between 48 hours and four days after
More informationPost-surgical V.A.C. VeraFlo Therapy with Prontosan Instillation on Inpatient Infected Wounds * COLLECTION OF CASE STUDIES
COLLECTION OF CASE STUDIES Post-surgical V.A.C. VeraFlo Therapy with Prontosan Instillation on Inpatient Infected Wounds * *All patients were treated with systemic antibiotics Post-surgical V.A.C. VeraFlo
More informationStop painful dressing changes!*
Stop painful dressing changes!* Apply it, leave it,* help heal it * AQUACEL Ag BURN and AQUACEL BURN dressings provide a comfortable environment while the dressing is in situ or upon removal. Although
More informationReimbursement guide. IODOSORB and IODOFLEX are Cadexomer Iodine Dressings which are available in a gel or pad format.
Reimbursement guide IODOSORB and IODOFLEX are Cadexomer Iodine Dressings which are available in a gel or pad format. IODOSORB and IODOFLEX remove barriers to healing and reduce pain and odor associated
More informationThe population of the United Kingdom is
Wound care in five English NHS Trusts: Results of a survey KEY WORDS Ageing Infection Survey Wound Wound dressing Karen Ousey Reader Advancing Clinical Practice, School of Human and Health Sciences, University
More information7/11/2011. Pressure Ulcers. Moisture-NOT Pressure. Wounds NOT Caused by Pressure
Assessment and Documentation of Pressure Ulcers Jeri Ann Lundgren, RN, BSN, PHN, CWS, CWCN Pathway Health Services July 19, 2011 Training Objectives Describe etiologies of pressure ulcers Discuss how to
More informationTreating Pressure Ulcers: When, How and What to expect when using MEDIHONEY and the primary topical intervention
Treating Pressure Ulcers: When, How and What to expect when using MEDIHONEY and the primary topical intervention Presenter: Peg Manochi, RN, BSN, WCC, CWCN Clinical Field Specialist Derma Sciences, Clinical
More informationFACULTY OF MEDICAL SCIENCE
Doctor of Philosophy Program in Microbiology FACULTY OF MEDICAL SCIENCE Naresuan University 171 Doctor of Philosophy Program in Microbiology The time is critical now for graduate education and research
More informationThe use of MEDIHONEY in Palliative Wound Care and the Advanced Aging Patient
The use of MEDIHONEY in Palliative Wound Care and the Advanced Aging Patient Presenter: Angel Sutton, RN, MSN/Ed, CWCN, CFCN, CCCN Wound Care Nurse Consultant Agenda My clinical practice Why MEDIHONEY?
More informationIntroduction to Infection Control
CHAPTER 3 Introduction to Infection Control George Byrns and Mary Elkins Learning Objectives 1 Define terms used in infection control. 2. Review significant risk factors for infection. 3. Identify the
More informationHCPCS AMERIGEL HYDROGEL DRESSINGS CODING GUIDANCE FOR:
HCPCS CODING GUIDANCE FOR: AMERIGEL HYDROGEL DRESSINGS FORM 1500 MUST HAVE THE FOLLOWING: APPROPRIATE HCPCS CODE APPROPRIATE A MODIFIER ACCURATE POS = 12 The Centers for Medicare and Medicaid Services
More informationMEDIZINISCHE PUBLIKATIONEN
Re Print MEDIZIN & PRAXIS Spezial Infected Wounds Has Cutisorb Sorbact proved its practical value as an antibacterial dressing? B. v. Hallern, Copyright 2005 by Verlag für MEDIZINISCHE PUBLIKATIONEN Bernd
More informationHighlights of the Revised Official ICD-9-CM Guidelines for Coding and Reporting Effective October 1, 2008
Highlights of the Revised Official ICD-9-CM Guidelines for Coding and Reporting Effective October 1, 2008 Please refer to the complete ICD-9-CM Official Guidelines for Coding and Reporting posted on this
More informationIntroduction to Wound Management
EWMA Educational Development Programme Curriculum Development Project Education Module: Introduction to Wound Management Latest revision: October 2012 ABOUT THE EWMA EDUCATIONAL DEVELOPMENT PROGRAMME The
More informationSCOPE: Western Australia CLINICAL PROTOCOL - MINOR SURGICAL PROCEDURES. Introduction
SCOPE: Western Australia CLINICAL PROTOCOL - MINOR SURGICAL PROCEDURES Introduction To provide appropriate management of wounds, there are occasions where either wound biopsy or sharp debridement procedures
More informationSkin Care In Bladder And Bowel Dysfunction Wendy Ness Colorectal Nurse Specialist
Skin Care In Bladder And Bowel Dysfunction Wendy Ness Colorectal Nurse Specialist Function Of The Skin Healthy skin serves several purposes it protects the internal organs physically, chemically and biologically
More informationSkin Care Educational Pocket Guide
Skin Care Educational Pocket Guide Moisture-Associated Skin Damage Moisture-Associated Skin Damage is the injury to the skin by repeated or sustained exposure to moisture. Intertriginous dermatitis Incontinence-associated
More informationNeutral Superoxidized solution vs. benzoyl peroxide gel 5% in the treatment of. Superoxidized solution (SOS) is an electrochemically processed aqueous
Neutral Superoxidized solution vs. benzoyl peroxide gel 5% in the treatment of acne vulgaris: a randomized open-label clinical trial. Summary. Superoxidized solution (SOS) is an electrochemically processed
More informationOriginal Article Honey compared with 1% silver sulfadiazine cream in the treatment of superficial and partial thickness burns
Original Article Honey compared with 1% silver sulfadiazine cream in the treatment of superficial and partial thickness burns Asher Ahmed Mashhood*, Tahir Ahmed Khan**, Ahmed Nurus Sami * Department of
More information7/30/2012. Increased incidence of chronic diseases due
Dianne Rudolph, DNP, GNP bc, CWOCN Discuss management of wound care in older adults with focus on lower extremity ulcers Identify key aspects of prevention Explain basic principles of wound management
More informationDiabetic Foot Ulcers and Pressure Ulcers. Laurie Duckett D.O. Plastic and Reconstructive Surgeon Oklahoma State University Center for Health Sciences
Diabetic Foot Ulcers and Pressure Ulcers Laurie Duckett D.O. Plastic and Reconstructive Surgeon Oklahoma State University Center for Health Sciences Lecture Objectives Identify risk factors Initiate appropriate
More informationAn evaluation of the efficacy of Cutimed Sorbact in different types of non-healing wounds Sylvie Hampton
Wounds UK An evaluation of the efficacy of Cutimed Sorbact in different types of non-healing wounds Sylvie Hampton Wounds UK, 2007, Vol 3, No 1 1 An evaluation of the efficacy of Cutimed Sorbact in different
More informationDisc Diffusion Susceptibility Methods
Disc Diffusion Susceptibility Methods Introduction When a filter paper disc impregnated with a chemical is placed on agar the chemical will diffuse from the disc into the agar. This diffusion will place
More informationTREATMENT OF PERITONEAL DIALYSIS (PD) RELATED PERITONITIS. General Principles
WA HOME DIALYSIS PROGRAM (WAHDIP) GUIDELINES General Principles 1. PD related peritonitis is an EMERGENCY early empiric treatment followed by close review is essential 2. When culture results and sensitivities
More informationWirral University Teaching Hospital NHS Foundation Trust
Clinical guideline Wound dressings Guidance for Use There are several types of dressings in use at Wirral University Teaching Hospitals (WUTH). These are: 1. Medicated dressings a) Hydrocolloid dressings
More informationState of Kuwait Ministry of Health Infection Control Directorate. Guidelines for Prevention of Surgical Site Infection (SSI)
State of Kuwait Ministry of Health Infection Control Directorate Guidelines for Prevention of Surgical Site Infection (SSI) September 1999 Updated 2007 Surgical Wound: According to 1998 Kuwait National
More informationAddressing the challenge of healthcare associated infections (HCAIs) in Europe
POSITION PAPER 05 January 2011 Addressing the challenge of healthcare associated infections (HCAIs) in Europe A Call for Action Page 1 of 8 A holistic approach to combating HCAIs in Europe We must rise
More informationA normal eye is protected by a layer of natural tears.
A normal eye is protected by a layer of natural tears. If you need to use eye drops several times a day to make your eyes comfortably moist, you should consult your eye doctor. Helps increase tear production
More informationCOMPOUNDING PHARMACY SOLUTIONS PRESCRIPTION COMPOUNDING FOR DERMATOLOGY
JUNE 2012 COMPOUNDING PHARMACY SOLUTIONS PRESCRIPTION COMPOUNDING WWW.CPSRXS. COM We customize individual prescriptions for the specific needs of our patients. INSIDE THIS ISSUE: Acne 2 Cutaneous Candidiasis
More informationEAST CAROLINA UNIVERSITY INFECTION CONTROL POLICY. Methicillin-resistant Staph aureus: Management in the Outpatient Setting
EAST CAROLINA UNIVERSITY INFECTION CONTROL POLICY Methicillin-resistant Staph aureus: Management in the Outpatient Setting Date Originated: Date Reviewed: Date Approved: Page 1 of Approved by: Department
More informationHydrozole Cream Hydrocortisone (microfine) 1% w/w and Clotrimazole 1% w/w
CONSUMER MEDICINE INFORMATION What is in this leaflet? This leaflet answers some common questions about Hydrozole It does not contain all the available information. It does not take the place of talking
More informationPRESSURE ULCER GUIDELINES FOR TOPICAL TREATMENT
PRESSURE ULCER GUIDELINES FOR TOPICAL TREATMENT The following are suggested guidelines for treatment of pressure ulcers using products from Swiss-American Products, Inc. and are intended to supplement
More informationWound bed preparation: TIME in practice
Wound bed preparation: TIME in practice Wound bed preparation is now a well established concept and the TIME framework has been developed as a practical tool to assist practitioners when assessing and
More informationUse of Packing for Surgical Wounds. Maggie Benson Clinical Problem Solving II
Use of Packing for Surgical Wounds Maggie Benson Clinical Problem Solving II Purpose Present patient management s/p Incision and Drainage in an outpatient setting Examine evidence for the use of wound
More information3M Steri-Strip S Surgical Skin Closure. Commonly Asked Questions
3M Steri-Strip S Surgical Skin Closure Commonly Asked Questions What are the indications for use of 3M Steri-Strip S Surgical Skin Closure? Steri-Strip S Surgical Skin Closures are indicated as a primary
More informationUrinary Tract Infections
Urinary Tract Infections Leading cause of morbidity and health care expenditures in persons of all ages. An estimated 50 % of women report having had a UTI at some point in their lives. 8.3 million office
More informationCCME CNE Course Announcement
CCME CNE Course Announcement Activity Title: NoCVA Pressure Ulcer Webinar The Carolinas Center for Medical Excellence (CCME) is accredited as an approved provider of continuing nursing education by North
More informationWOUND EXUDATE: WHAT IT IS AND HOW TO MANAGE IT
WOUND EXUDATE: WHAT IT IS AND HOW TO MANAGE IT Wound exudate plays an essential role in wound healing by providing a moist wound bed and a supply of necessary nutrients. Understanding what causes changes
More informationWound Management A Nurse s Guide
VEA Bringing Learning to Life Program Support Notes Wound Management A Nurse s Guide Health Care 20 mins Teacher Notes by Tracey MacFadyen, Registered nurse is RN. Clinical Nurse Educator Produced by VEA
More information* This policy is under review and is being updated. A revised policy will be added shortly * February 2009. Clinical Development Forum
* This policy is under review and is being updated. A revised policy will be added shortly * Document Title: PCT Document Ref No.: Local Document Ref No.: Date of Approval: Approved by: Guidance for the
More informationCatheter-Associated Urinary Tract Infection (CAUTI) Prevention. Basics of Infection Prevention 2 Day Mini-Course 2013
Catheter-Associated Urinary Tract Infection (CAUTI) Prevention Basics of Infection Prevention 2 Day Mini-Course 2013 2 Objectives Define the scope of healthcare-associated urinary tract infections (UTI)
More informationMonitoring surgical wounds for infection
Monitoring surgical wounds for infection Information for patients This leaflet explains surgical wound infection and the national programme for monitoring infections acquired in hospitals This hospital
More informationAre venous catheters safe in terms of blood tream infection? What should I know?
Are venous catheters safe in terms of blood tream infection? What should I know? DIAGNOSIS, PREVENTION AND TREATMENT OF HAEMODIALYSIS CATHETER-RELATED BLOOD STREAM INFECTIONS (CRBSI): A POSITION STATEMENT
More information10. Treatment of peritoneal dialysis associated fungal peritonitis
10. Treatment of peritoneal dialysis associated fungal peritonitis Date written: February 2003 Final submission: July 2004 Guidelines (Include recommendations based on level I or II evidence) The use of
More informationManagement of Burns. The burns patient has the same priorities as all other trauma patients.
Management of Burns The burns patient has the same priorities as all other trauma patients. Assess: - Airway - Breathing: beware of inhalation and rapid airway compromise - Circulation: fluid replacement
More informationSilicone pressure-reducing pads for the prevention and treatment of pressure ulcers
S46 Product focus Silicone pressure-reducing pads for the prevention and treatment of pressure ulcers Abstract Pressure ulcers, a key quality of care indicator, cause emotional distress to the patient,
More informationPressure Ulcer Passport
Pressure Ulcer Passport Information for patients This is a record of the treatment you are receiving for your pressure ulcer injury. Please bring it with you to all your healthcare appointments. This will
More informationPressure injuries prevention and treatment
After 30 years in wound care, we at Coloplast believe that absorption is the key to better healing. Our Biatain portfolio brings superior absorption to daily wound care needs, making Biatain the simple
More informationThe Use of MEDIHONEY for Wound Management in Oncology
The Use of MEDIHONEY for Wound Management in Oncology Presenter: Patrice M. Dillow, MSN, APRN, CWOCN Cancer Treatment Centers of America Midwestern Regional Medical Center A Magnet Hospital This presentation
More informationOASIS-C Integument Assessment: Not for Wimps! Part I: Pressure Ulcers
OASIS-C Integument Assessment: Not for Wimps! Part I: Pressure Ulcers Presented by: Rhonda Will, RN, BS, COS-C, HCS-D Assistant Director, OASIS Competency Institute 243 King Street, Suite 246 Northampton,
More informationCertofix protect More certainty, more safety, more success
Certofix protect More certainty, more safety, more success Highly effective, long-term protection against catheter infection Central Venous Catheters Antimicrobial modified hydrophilic surface We help
More informationChapter 4 Physiological Therapeutics. 2 Superficial Heat
Chapter 4 Physiological Therapeutics 2 Superficial Heat Date revised 8/27/03 Superficial Heat PHYSIOLOGICAL EFFECTS OF HEAT APPLICATION 1. Increases blood flow 5. Promotes abnormal ossification 2. Increases
More informationHow To Stage A Pressure Ulcer
WOCN Society Position Statement: Pressure Ulcer Staging Originated By: Wound Committee Date Completed: 1996 Reviewed/Revised: July 2006 Revised: August 2007 Reviewed/Revised: April 2011 Definition of Pressure
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Aknemycin Solution 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 10 g of solution contains 0.2 g of erythromycin. Structural formula of
More informationChapter 4 Physiological Therapeutics. 1 Cryotherapy
Chapter 4 Physiological Therapeutics 1 Cryotherapy CRYOTHERAPY PHYSIOLOGIC EFFECTS OF ICE APPLICATION 1. Decreased circulation 5. Increased tissue stiffness 2. Local vasoconstriction 6. Decreased muscle
More informationCEFA-DROPS AND CEFA-TABS
Page 1 of 5 FORT DODGE ANIMAL HEALTH Division of Wyeth 800-5TH STREET N.W., P.O. BOX 518 FORT DODGE IA 50501 USA Telephone: 515-955-4600 Fax: 515-955-3730 Order Desk Telephone: 800-685-5656 Order Desk
More informationGeneral Trends in Infectious Disease
General Trends in Infectious Disease Four phenomena underline the increase in ID problems: Aging population Increasing numbers of immunocompromised patients Increased mobility of the population Newly emerging
More informationUse of a Pressure Ulcer Protocol: Benefits and Recommendations
Use of a Pressure Ulcer Protocol: Benefits and Recommendations Elizabeth L. Enriquez RN,BSN,MPH,CWOCN Wound Care Specialist/Infection Control Morningiside House 1000 Pellham Parkway, Bronx, NY 10461 Wound
More informationAntibiotic resistance does it matter in paediatric clinical practice? Jette Bangsborg Department of Clinical Microbiology Herlev Hospital
Antibiotic resistance does it matter in paediatric clinical practice? Jette Bangsborg Department of Clinical Microbiology Herlev Hospital Background The Department of Clinical Microbiology at Herlev Hospital
More informationPowerLight LED Light Therapy. The FUTURE of corrective skin
PowerLight LED Light Therapy The FUTURE of corrective skin care TODAY LED facial treatments Effective when used with correct protocols Non thermal stimulation of collagen Increases circulation and lymphatic
More information`TORAY TEXTILES EUROPE
`TORAY TEXTILES EUROPE See It Safe ANTI-MICROBIAL TEST RESULTS October 2006 Antimicrobial Test Methods Used ' TORAY' AATCC 147 (Modified) Antibacterial Activity Assessment of Tetile Materials: Parallel
More informationImplementing Biofilm and Infection 2014 Guidelines
Implementing Biofilm and Infection 2014 Guidelines Joyce K Stechmiller, PhD, FAAN Professor and Chair, Dept of Adult Nursing Gregory Schultz, PhD Professor ObGyn, Director Institute Wound Research Conflict
More informationABThera Open Abdomen Negative Pressure Therapy for Active Abdominal Therapy. Case Series
ABThera Open Abdomen Negative Pressure Therapy for Active Abdominal Therapy Case Series Summary of Cases: USER EXPERIENCE The ABThera OA NPT system was found by surgeons to be a convenient and effective
More informationRENFREW VICTORIA HOSPITAL SKIN AND WOUND CARE PROGRAM TRAINING RISK ASSESSMENT OF SKIN BREAKDOWN AND TREATMENT OF WOUNDS AND PRESSURE ULCERS
RENFREW VICTORIA HOSPITAL SKIN AND WOUND CARE PROGRAM TRAINING RISK ASSESSMENT OF SKIN BREAKDOWN AND TREATMENT OF WOUNDS AND PRESSURE ULCERS SELF-LEARNING MODULE For Registered Nurses and Registered Practical
More informationMaharishi Honey. has. August 2004. Page 1
Maharishi Vedic Organic Apiculture TM 15 August 2004 TM has Vitalquality as measured in considered superior to other high quality honeys. Other Honey previously considered to be of high quality. Other
More information